Trial intelligence / Profile preview

Ciprofol vs propofol for general anesthesia in adult valve replacement surgery with cardiopulmonary bypass

ChiCTR2600117273Phase 4Not yet recruiting

Sponsor
Meishan Municipal People's Hospital
Start
Jan 2026
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol in Cardiac valve disease (VHD) (2 arms), sponsored by Meishan Municipal People's Hospital. Primary endpoints: Post-induction hypotension (PIH) and Total dose of norepinephrine used. Planned start Jan 2026; status: not yet recruiting.

02

Drugs

ciprofol
03

Conditions

Cardiac valve disease (VHD)

Beyond the preview

Go deeper on ChiCTR2600117273.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600117273.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call